Diego Arango Del Corro
Grau: Doctor/a
darango(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/M-5667-2016
Grups
Publicacions
-
Vanharanta S; Wortham NC; Laiho P; Sjöberg J; Aittomäki K; Arola J; Tomlinson IP; Karhu A; Arango D; Aaltonen LA
7q deletion mapping and expression profiling in uterine fibroids.
ONCOGENE 24 6545-6554. .
-
Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
Gastroenterology 129 874-884. .
-
Kruhøffer M; Jensen JL; Laiho P; Dyrskjøt L; Salovaara R; Arango D; Birkenkamp-Demtroder K; Sørensen FB; Christensen LL; Buhl L; Mecklin JP; Järvinen H; Thykjaer T; Wikman FP; Bech-Knudsen F; Juhola M; Nupponen NN; Laurberg S; Andersen CL; Aaltonen LA; Ørntoft TF
Gene expression signatures for colorectal cancer microsatellite status and HNPCC.
BRITISH JOURNAL OF CANCER 92 2240-2248. .
-
Mariadason JM; Nicholas C; L'Italien KE; Zhuang M; Smartt HJ; Heerdt BG; Yang W; Corner GA; Wilson AJ; Klampfer L; Arango D; Augenlicht LH
Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis.
Gastroenterology 128 1081-1088. .
-
Arango D; Wilson AJ; Shi Q; Corner GA; Arañes MJ; Nicholas C; Lesser M; Mariadason JM; Augenlicht LH
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.
BRITISH JOURNAL OF CANCER 91 1931-1946. .
-
Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
HUMAN MOLECULAR GENETICS 13 2303-2311. .
-
Mariadason JM; Arango D; Augenlicht LH
Customizing chemotherapy for colon cancer: the potential of gene expression profiling.
DRUG RESISTANCE UPDATES 7 209-218. .
-
Mariadason JM; Arango D; Shi Q; Wilson AJ; Corner GA; Nicholas C; Aranes MJ; Lesser M; Schwartz EL; Augenlicht LH
Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.
CANCER RESEARCH 63 8791-8812. .
-
Klampfer L; Huang J; Corner G; Mariadason J; Arango D; Sasazuki T; Shirasawa S; Augenlicht L
Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression.
Journal Of Biological Chemistry 278 46278-46287. .
-
Arango D; Mariadason JM; Wilson AJ; Yang W; Corner GA; Nicholas C; Aranes MJ; Augenlicht LH
c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.
BRITISH JOURNAL OF CANCER 89 1757-1765. .
-
Wilson AJ; Arango D; Mariadason JM; Heerdt BG; Augenlicht LH
TR3/Nur77 in colon cancer cell apoptosis.
CANCER RESEARCH 63 5401-5407. .
-
Augenlicht LH; Velcich A; Klampfer L; Huang J; Corner G; Aranes M; Laboisse C; Rigas B; Lipkin M; Yang K; Shi Q; Lesser M; Heerdt B; Arango D; Yang W; Wilson A; Mariadason JM
Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.
Journal Of Nutrition 133 -. .
Projectes
- Contratos predoctorales de formación en investigación en salud (PFIS)
- Nueva aproximación terapéutica para el cáncer colorectal.
- EPH Receptor Signaling in Endometrial Cancer
- Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
- Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
- Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
- Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
- Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
- Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy